A way to organize research questions
For drug development, phases describe stages of clinical research. Phase 1 generally focuses on safety and dosage. Phase 2 explores effectiveness and continues safety assessment. Phase 3 studies effectiveness and adverse reactions in larger groups. Phase 4 research takes place after approval and can add information about use and safety.
Those descriptions are a starting point. Study designs differ, and a phase number alone cannot explain the amount of time, uncertainty or benefit involved for a particular participant.
Turn the phase into useful questions
When a study page says ‘Phase 2,’ use that information to begin a conversation rather than to grade the study. Ask what has already been learned and what remains unknown. The answer should relate to the actual study product and population, not only a general description of that phase.
- What is the main question this study is designed to answer?
- What information is available from earlier research?
- Which uncertainties are most important for me to understand?
- How does this study differ from the usual options for my condition?
- What is the plan if I need to stop participating?
Look beyond the number
Put the phase beside other practical details: study duration, visit schedule, procedures, assignment to groups and location. Two studies with the same phase may have very different demands. A larger number is not a personal recommendation, and an earlier number does not by itself describe every risk.
The study comparison tool gives you space to organize these details side by side. Leave an answer marked ‘unknown’ until a research team confirms it. A clear list of unanswered questions is more useful than a confident guess.
Sources & further reading
Educational content. Use these resources to prepare a conversation with your care and research teams. Study-specific information must be confirmed with the team.